Patient and Physician Perspectives on Non-Alcoholic Fatty Liver Disease
NCT04132440 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 17
Last updated 2026-02-19
Summary
This trial studies patient and physician perspectives on non-alcoholic fatty liver disease. Using questionnaires and interviews, this trial may help researchers understand physicians' knowledge about the diagnosis, prognosis, treatment and management of non-alcoholic fatty liver disease, as well as gain an in-depth understanding of Hispanic patients' perceptions about the disease and investigate how cultural factors may play a role in its diagnosis, treatment and management.
Conditions
- Nonalcoholic Fatty Liver Disease
- Physician
Interventions
- OTHER
-
Interview
Complete interview
- OTHER
-
Questionnaire Administration
Complete questionnaire
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Lorna McNeill · M.D. Anderson Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-08-22
- Primary Completion
- 2030-05-01
- Completion
- 2030-05-01
Countries
- United States
Study Locations
More Related Trials
-
Quality of Life in Non-alcoholic Fatty Liver Disease (QOLNAFLD)
NCT03613480 ·Status: UNKNOWN ·Phase: NA
-
Testing a Multilevel, Culturally Appropriate Lifestyle Intervention For Hispanic Patients With Metabolic Dysfunction-associated Steatotic Liver Disease
NCT07199491 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study
NCT04550481 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Clinical Performance of LIVERFASt Test Compared w/ Liver Biopsy in Patients w/ NAFLD.
NCT04579874 ·Status: COMPLETED ·Phase: NA
-
Nutritional Intervention IN Nash NON-ALCOHOLIC (NAFLD).
NCT05946330 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Aerobic and Resistant Exercise Training in Patients With Non-Alcoholic Steatohepatitis
NCT05065593 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Metabolic Cofactor Supplementation in Obese Patients With Non-Alcoholic Fatty Liver Disease
NCT04330326 ·Status: COMPLETED ·Phase: PHASE2
-
Nonalcoholic Fatty Liver Disease (NAFLD) Database 3
NCT04454463 ·Status: COMPLETED
-
Non Alcoholic Fatty Liver Disease Influence of Statin Therapy
NCT00375349 ·Status: WITHDRAWN ·Phase: NA
-
Development of a Novel Asian Mediterranean Diet and Its Acceptability in NAFLD
NCT06321211 ·Status: COMPLETED
-
RCT of Caloric Restriction vs. Alternate-Day Fasting in Non-Alcoholic Fatty Liver Disease
NCT03365531 ·Status: TERMINATED ·Phase: NA
-
Diabetes Prevention Program for the Treatment of Nonalcoholic Fatty Liver Disease
NCT04988204 ·Status: COMPLETED ·Phase: NA
-
Manual Therapy in Metabolic Liver Disease
NCT06338618 ·Status: COMPLETED ·Phase: NA
-
Efficacy of N-Acetylcysteine in Improving/Normalizing ALT & AST in Patients of NAFLD
NCT05576428 ·Status: UNKNOWN ·Phase: NA
-
Effect of Indo-Mediterranean Diet on Hepatic Steatosis and Fibrosis in NAFLD Children
NCT05073588 ·Status: COMPLETED ·Phase: NA
-
ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD)
NCT05006885 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Efficacy, Safety and Tolerability of LCQ908 in NAFLD Patients
NCT01811472 ·Status: COMPLETED ·Phase: PHASE2
-
Probiotics in NASH Patients - PROBILIVER TRIAL
NCT03467282 ·Status: UNKNOWN ·Phase: NA
-
Smartphone App for Non-alcoholic Fatty Liver Disease
NCT05180760 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD)
NCT03248882 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related Cirrhosis
NCT06773221 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Extension of ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With (NAFLD)
NCT05292911 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Empagliflozin on Liver Fat in Non-diabetic Patients
NCT04642261 ·Status: COMPLETED ·Phase: PHASE4
-
A Study To Assess Pharmacodynamics, Safety And Tolerability Of PF-05221304 And PF-06865571 Co-Administered For 6 Weeks In Adults With Non-Alcoholic Fatty Liver Disease.
NCT03776175 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of Endothelial Function in Patients With Non Alcoholic Fatty Liver Disease and the Impact of Statin Treatment
NCT01987310 ·Status: WITHDRAWN ·Phase: NA